Ventyx Biosciences, Inc.
Ventyx Biosciences, Inc. (VTYX) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · VTYX · as of Sep 30, 2025
Ownership Breakdown
115
Institutional Holders
▼ 3 vs Q2
$136.38M
Total Inst. Value
▲ $41.31M vs Q2
71.75M
Shares Outstanding
freeFloat 66.70%
43.85M
13F Shares Held
▼ 576,756 vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
VTYX largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
AFFINITY ASSET ADVISORS, LLC pharmaceutical preparations | 3.92M | 5.51% | 5.51% | $12.20B | Nov 13, 2025 | ▼ 611.8K |
VANGUARD GROUP INC pharmaceutical preparations | 3.77M | 5.29% | 5.29% | $11.72B | Nov 7, 2025 | ▲ 607.7K |
POINT72 ASSET MANAGEMENT, L.P. pharmaceutical preparations | 3.21M | 4.51% | 4.51% | $9.98B | Nov 14, 2025 | ▼ 2.69M |
TANG CAPITAL MANAGEMENT LLC pharmaceutical preparations | 3.10M | 4.35% | 4.35% | $9.64B | Nov 14, 2025 | — held |
MARSHALL WACE, LLP pharmaceutical preparations | 2.32M | 3.25% | 3.25% | $7.20B | Nov 13, 2025 | ▼ 80.5K |
VESTAL POINT CAPITAL, LP pharmaceutical preparations | 2.05M | 2.88% | 2.88% | $6.38B | Nov 14, 2025 | ▲ 50.0K |
CITADEL ADVISORS LLC pharmaceutical preparations | 1.88M | 2.64% | 2.64% | $5.85B | Nov 14, 2025 | ▲ 114.5K |
MILLENNIUM MANAGEMENT LLC pharmaceutical preparations | 1.65M | 2.32% | 2.32% | $5.14B | Nov 14, 2025 | ▲ 246.0K |
IKARIAN CAPITAL, LLC pharmaceutical preparations | 1.31M | 1.84% | 1.84% | $4.07B | Nov 14, 2025 | ▲ 342.0K |
BLACKROCK, INC. pharmaceutical preparations | 1.18M | 1.66% | 1.66% | $3.68B | Nov 12, 2025 | ▼ 184.8K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
24
Increased
+3.92M shares8
New Positions
first time holders15
Decreased
−6.39M shares0
Sold Out
fully exitedNet shares change (top 50)
2.47M
+3.92M / −6.39M
Net new holders
+17
8 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
VTYX insider trading · insider activity
Source: SEC Form 4
0
Buy transactions
57
Sell transactions
0.00
Buy/Sell ratio
$13M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Gonzales Roy Senior VP, Finance | Mar 4, 2026 | D-Return | 5,313 | $14.00 | $74.4K | 0 | Form 4 ↗ |
Gonzales Roy Senior VP, Finance | Mar 4, 2026 | D-Return | 37,500 | $2.14 | $80.3K | 0 | Form 4 ↗ |
Gonzales Roy Senior VP, Finance | Mar 4, 2026 | D-Return | 70,000 | $33.84 | $2.37M | 0 | Form 4 ↗ |
Gonzales Roy Senior VP, Finance | Mar 4, 2026 | D-Return | 12,500 | $4.67 | $58.4K | 0 | Form 4 ↗ |
Gonzales Roy Senior VP, Finance | Mar 4, 2026 | D-Return | 35,000 | $2.49 | $87.2K | 0 | Form 4 ↗ |
Subramaniam Somu director | Mar 4, 2026 | D-Return | 15,937 | $34.83 | $555.1K | 0 | Form 4 ↗ |
Subramaniam Somu director | Mar 4, 2026 | D-Return | 40,000 | $2.25 | $90.0K | 0 | Form 4 ↗ |
Subramaniam Somu director | Mar 4, 2026 | D-Return | 3,337,495 | $14.00 | $46.72M | 0 | Form 4 ↗ |
Subramaniam Somu director | Mar 4, 2026 | D-Return | 33,000 | $3.29 | $108.4K | 0 | Form 4 ↗ |
Subramaniam Somu director | Mar 4, 2026 | D-Return | 20,000 | $1.97 | $39.4K | 0 | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Ventyx Biosciences, Inc. (VTYX) is primarily owned by institutional investors, who hold approximately 61.1% of total shares outstanding. Company insiders own approximately 33.30%, while retail and public investors account for the remaining 5.58%.
The largest institutional shareholder of Ventyx Biosciences, Inc. is AFFINITY ASSET ADVISORS, LLC, holding approximately 3.92 million shares — equal to 5.51% of outstanding shares — as of September 30, 2025.
A total of 115 institutional investors currently hold VTYX stock, with a combined institutional value of approximately $136,379,005 as of the most recent 13F filing period.
Frequently asked questions
VTYX ownershipVentyx Biosciences, Inc. (VTYX) is primarily owned by institutional investors, who hold approximately 61.1% of shares. The largest shareholder is AFFINITY ASSET ADVISORS, LLC with a 5.51% stake. Company insiders hold 33.30%. Data sourced from SEC Form 13F as of September 30, 2025.